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Heterozygous mutations in the KCNQ3 gene on chromosome 8q24 encoding the voltage-
gated potassium channel KV7.3 subunit have previously been associated with rolandic
epilepsy and idiopathic generalized epilepsy (IGE) including benign neonatal convulsions.
We identified a de novo t (3;8) (q21;q24) translocation truncating KCNQ3 in a boy with
childhood autism. In addition, we identified a c.1720C>T [p.P574S] nucleotide change
in three unrelated individuals with childhood autism and no history of convulsions. This
nucleotide change was previously reported in patients with rolandic epilepsy or IGE and
has now been annotated as a very rare SNP (rs74582884) in dbSNP. The p.P574S KV7.3
variant significantly reduced potassium current amplitude in Xenopus laevis oocytes when
co-expressed with KV7.5 but not with KV7.2 or KV7.4. The nucleotide change did not affect
trafficking of heteromeric mutant KV7.3/2, KV7.3/4, or KV7.3/5 channels in HEK 293 cells or
primary rat hippocampal neurons. Our results suggest that dysfunction of the heteromeric
KV7.3/5 channel is implicated in the pathogenesis of some forms of autism spectrum disor-
ders, epilepsy, and possibly other psychiatric disorders and therefore, KCNQ3 and KCNQ5
are suggested as candidate genes for these disorders.
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INTRODUCTION
Autism spectrum disorders (ASD, OMIM 209850) are neurode-
velopmental disorders with early childhood onset and a lifelong
persistence. They are characterized by severe impairments in reci-
procal social interaction and communication as well as by stereo-
typic behavior or interests. The prevalence of ASDs is estimated to
be 9 in 1000 (Autism and Developmental Disabilities Monitoring
Network, 2009; Baron-Cohen et al., 2009) with a male to female
ratio of 4:1 (Folstein and Rosen-Sheidley, 2001). Intellectual dis-
ability (ID) occurs in approximately 50% of ASD individuals;
approximately 20–30% have comorbid epilepsy (State, 2010; Tuch-
man et al., 2010; Kohane et al., 2012) Furthermore, 72% of children
diagnosed with ASD have at least one additional psychiatric disor-
der such as attention deficit hyperactivity disorder (ADHD), major
depression, schizophrenia, phobia, obsessive compulsive disorder
(OCD) (Stahlberg et al., 2004; Leyfer et al., 2006; Abdallah et al.,
2011). Common genetic etiologies have been identified for ASD,
ID, epilepsy and various psychiatric disorders which emphasizes
the likely overlap in pathogenesis for these disorders (Moreno-De-
Luca et al., 2010; Gregor et al., 2011; Duong et al., 2012). Twin and
family studies show that genetic factors are of profound impor-
tance for the development of ASD (Folstein and Rutter, 1977;
Bailey et al., 1995), but only few genes have been accepted as
ASD susceptibility genes. Likely explanations are the apparently
high degree of locus heterogeneity rendering it difficult to iden-
tify mutations in a gene in a convincing number of patients, the
pleiotropic effects of many neuronal disease genes making the con-
nection between genotype and phenotype less obvious (Duong
et al., 2012; Iossifov et al., 2012; O’Roak et al., 2012), and the likely
substantial contribution of de novo mutations (Sebat, 2007; Levy
et al., 2011; Iossifov et al., 2012; Neale et al., 2012). In addition,
point mutations (Jamain et al., 2003; Feng et al., 2006; Berkel et al.,
2010; O’Roak et al., 2012), rare genomic copy number variants
(CNVs), and recurrent CNVs (Ullmann et al., 2007; de Kovel et al.,
2010; Moreno-De-Luca et al., 2010) that increase the risk of ASD
and/or epilepsy, ID, and psychiatric disorders may be transmitted
from apparently normal parents.
Mutations in the genes KCNQ2 and KCNQ3 cause idiopathic
generalized epilepsy (IGE) (Neubauer et al., 2008). These include
benign neonatal epilepsy (Biervert et al., 1998; Charlier et al., 1998)
www.frontiersin.org April 2013 | Volume 4 | Article 54 | 1
Gilling et al. KV7.3/KV7.5 abnormalities associated with ASDs
Table 1 | Clinical description of three Portuguese individuals carrying a c.1720C>T variant and diagnosed with childhood autism.
Patient B Patient C Patient D
Current age 13 years 14 years 7 years
Born at gestational week 36 41 40
Apgar scores 10/5 8/5 9/5
Birth length, weight, head circumference 49 cm, 3760 g, 36 cm 50 cm, 3955 g, 37 cm 51 cm, 4290 g, 37,3 cm
Dysmorphic features No No No
Walking age 13 months 16 months 23 months
Age at first word 16 months 24 months 18 months
Age at first sentence 48 months Still not capable Still not capable
Current height, weight, head
circumference
50th percentile, 75th percentile,
+2SD
25th percentile, 25th percentile,
−2SD
50th percentile, 90th
percentile,+2SD
Neuronal examination Normal Normal Normal
Mental capacity WISC-III: verbal IQ 97,
performance IQ 84, global IQ 88
GDE (Griffiths, 1984): verbal IQ 46,
performance IQ 63, global IQ 61
GDE: verbal IQ 31,
performance IQ 67, global IQ 58
SNP inherited from Father Mother Father
Family history No neurological- or psychiatric
disorders
Mother: Major depression No neurological- or psychiatric
disorders
as well as benign childhood epilepsy with centrotemporal spikes
(rolandic epilepsy) (Neubauer et al., 2008) consistent with dysreg-
ulation of neuronal excitability. Intriguingly, >20% of patients
with rolandic epilepsy have cognitive deficits and >10% have
behavioral problems (ADHD, anxiety, depression, and pervasive
developmental disorder (PDD) (Tovia et al., 2011). Furthermore,
40% of patients with benign familial neonatal convulsions show
delayed psychomotor development or ID (Steinlein et al., 2007)
and >25% of patients with IGE have comorbid mental disor-
ders (Akanuma et al., 2008). KCNQ3 is one of five KCNQ genes
(KCNQ1-5) encoding the KV7 family of voltage-gated potas-
sium channels (Brown and Passmore, 2009). Four of these genes
(KCNQ2-5) are expressed in the central nervous system both on
RNA and protein level (Brown and Passmore, 2009) and are there-
fore excellent candidate susceptibility genes for a wide range of
neuronal disorders. KV7.3 forms heterotetrameric channels with
KV7.2 (Schroeder et al., 1998), KV7.4 (Kubisch et al., 1999), and
KV7.5 (Schroeder et al., 2000). KV7.2/KV7.3 heteromeric channels
primarily localize at the axon initial segment (AIS) and under-
lie the M-current involved in regulation of neuronal excitability
(Wang et al., 1998; Schroeder et al., 2000).
In this study we have investigated KCNQ3 gene variability in
two independent ASD cohorts from Portugal and Denmark.
MATERIALS AND METHODS
CLINICAL INFORMATION, PATIENT A
Patient A is a Danish boy who carries a de novo balanced translo-
cation t (3;8) (q21;q24). He was born in 1998 as the second
child of non-consanguineous, Caucasian, healthy parents aged
37 (mother) and 38 (father) at the time of birth. Both parents
have academic degrees. According to the parents the older sister
is both intellectually and socially very well-functioning. The preg-
nancy was normal and the delivery at gestational age 40+ 2 was
uncomplicated with Apgar scores 9/1 and 10/5. The birth weight
was 3900 g; birth length 53 cm; and head circumference 36 cm.
Growth parameters are currently still normal. No dysmorphic
features were noted at birth and hearing was normal.
In the neonatal period the parents noticed an abnormal social
interaction with him. Later on it was apparent that both ver-
bal and social development was delayed; however motor mile-
stones were achieved normally. Genetic testing for the fragile
X syndrome was negative and metabolic screening showed no
abnormalities. At 2 years of age he was diagnosed with child-
hood autism (Autism Diagnostic Observation Schedule type
G (ADOS-G); Communication score: 5, Social score: 14). At
8 years of age a WISC-III test showed a very uneven pro-
file with specific non-verbal visio-spatial difficulties (verbal
IQ= 103, performance IQ= 60, global IQ= 79). Currently, he
attends a class for children with special needs in a normal pri-
mary school. Verbally he is highly skilled in both Danish and
English.
Periodic idiopathic trembling was noted from the age of
2 days and according to the mother it persisted for the first
5 weeks. This description is in accordance with a diagnosis
of benign neonatal convulsions but this was never diagnosed.
Currently, he has no epilepsy diagnosis; however, according to
the parents he has brief episodes of non-responsiveness resem-
bling absence seizures. Consequently, electroencephalographic
(EEG) examination was carried out at ages 5 and 9 years during
sleep, hyperventilation, photo-stimulation, and during periods of
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FIGURE 1 | FISH mapping of translocation breakpoints reveals truncated
KCNQ3 gene in patient A. (A) Schematic depiction of the 26 kb breakpoint
region within chromosomal region 3q21.3 of patient A. The breakpoint region
is located 10.5 kb downstream of theTRH gene and contains no genes. (B)
Picture showing metaphase chromosomes from patient A (blue) hybridized
with the chromosome 3 specific probe RP11-93K22 (green) that spans the
breakpoint. The normal chromosome 3 as well as both derivative
chromosomes are marked with white arrows and enlarged in the boxes to the
right. (C)The 25 kb breakpoint region on chromosome 8 lies within intron 1 of
the KCNQ3 gene. (D)The chromosome 8 specific probe RP11-213I2 (green)
spans the breakpoint. The normal chromosome 8 as well as the two derivative
chromosomes are marked with white arrows and enlarged.
FIGURE 2 | c.1720C>T [p.P574S] variant detected in patient B, C and D.
(A)The c.1720 C>T mutation in patient B was identified by Sanger
sequencing. (B)The same mutation was identified in patient C and his
mother, in patient D and his father and confirmed in patient B and his father
by restriction enzyme cleavage of a PCR product encompassing the
mutation.
non-responsiveness but no abnormalities were observed. Cerebral
magnetic resonance (MR) scanning of the brain at age 8 years was
normal.
The National Ethics Committees and the Danish Data Pro-
tection Agency approved the study, and informed consent was
obtained from the parents.
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FIGURE 3 | Effect of KV7.3_P574S on KV7.2 and KV7.4 in X. laevis
oocytes. Currents were activated by voltage-steps from −80 mV to
+40 mV in 10 mV increments. Representative currents are shown as well
as steady-state current plotted as a function of voltage. (A) KV7.2 was
co-expressed with either KV7.3 WT (n=6) or P574S (n=5). (B) Effect of
KV7.3_P574S on KV7.4. KV7.4 was co-expressed with either KV7.3 WT (n=10)
or P574S (n= 13) in X. laevis oocytes.
PATIENTS AND CONTROL INDIVIDUALS FOR MUTATION SCREENING OF
KCNQ3
Mutation screening of KCNQ3 was performed in two steps.
As a first step DNA from a cohort comprising 100 Portuguese
and 48 Danish ASD patients were screened for KCNQ3 muta-
tions by direct sequencing. The Portuguese ASD patients were
recruited at the Hospital Pediátrico de Coimbra and all orig-
inated from mainland Portugal and the Azorean islands. The
male-female ratio was 4.8:1, and the ages ranged between 2 and
18 years (mean age 6.8 years). Idiopathic subjects were included
after clinical assessment and screening for known medical and
genetic conditions associated with autism, including testing
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FIGURE 4 | Effect of KV7.3_P574S on KV7.5. KV7.5 was expressed alone
(n=8) or co-expressed with either KV7.3 WT (n=7), P547S (n=6), or KV7.5
mixed with KV7.3 WT or KV7.3_P574S (in a 1:1 molar ratio, Hetero, n=6) in X.
laevis oocytes. Currents were activated by voltage-steps from −80 to
+40 mV in 10 mV increments. (A) Representative currents are shown. (B)
Steady-state current plotted as a function of voltage. Asterisks indicate
statistical difference between Hetero and KV7.3/KV7.5. Comparison of the
other points were left out for clarity and for voltages higher than 0 mV, all
points were statistically different.
for Fragile X mutations (FRAXA and FRAXE), chromosomal
abnormalities, neurocutaneous syndromes, endocrine (thyroid
function screening), and metabolic disorders. About 35 of
the 48 Danish ASD patients were recruited at child psy-
chiatric hospitals in the western part of Denmark (Jutland)
(age range 3–30 years, with mean age of 10 years and male-
female ratio of 3:1). Seven autistic patients were ascertained
at the Kennedy Center (Glostrup, Denmark) (age range 13–
37 years, mean age 20.4 and male-female ratio of 2.5:1). These
patients were unrelated and part of the IMGSAC group and
accordingly some of the patients had siblings and some even
additional relatives with a diagnosis of pervasive developmen-
tal disorder. These patients were screened for chromosomal
abnormalities and fragile X syndrome and a physical exam-
ination included a careful search for phakamatoses to rule
out Tuberous Sclerosis (TSC). Four patients diagnosed within
the autism spectrum were collected at the Psychiatric Hos-
pital in Hillerød (Frederiksborg Amt, Denmark). In addition,
two DNA samples (one male, one female) from individu-
als diagnosed within the ASD spectrum and with chromo-
somal rearrangements were included in the screening. These
samples were collected at the Wilhelm Johannsen Centre
for Functional Genome Research, University of Copenhagen
(Denmark). In all of the above ASD patients diagnosis
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FIGURE 5 | No effect of KV7.3_P574S on localization of the
KV7.2/KV7.3 complex in HEK 293 cells. KV7.2 was transiently
expressed in HEK 293 cells together with KV7.3 WT or KV7.3_P574S,
and the localization of the complex was analyzed by
immunocytochemistry and confocal microscopy. As illustrated, the
P574S mutation is without effect on the localization of the complex
that displays a primarily intracellular localization pattern. Scale bar
20µm.
was made in accordance with DSM-IV or ICD-10 criteria using
ADI-R in addition to ADOS or the Childhood Autism Rating
Scale.
The c.1720C>T variant in KCNQ3 was first identified in one
Portuguese ASD patient (patient B, Table 1) by direct sequencing.
As a next step 271 additional Portuguese ASD patients fulfilling the
same criteria as the first cohort were specifically screened for the
c.1720C>T variant by a PCR/enzyme cleavage assay whereby two
additional patients (patient C and D) were identified as carriers of
the c.1720C>T variant. Hence, a total of 419 ASD patients (371
Portuguese- and 48 Danish ASD patients) were screened for the
c.1720C>T variant. The three male Portuguese patients (Patient
B, C, D in Table 1) were diagnosed with childhood autism using
the Autism Diagnostic Interview-Revised (ADI-R) and ADOS
(Lord et al., 1994) and had no history of convulsions. The inheri-
tance pattern of the c.1720C>T variant was ascertained both by
direct sequencing of exon 13 of KCNQ3 and by the PCR/enzyme
cleavage assay in patient B, C, and D and their parents. As con-
trols 96 Caucasian individuals from the Human Random Con-
trol DNA panel (HRC-1, Sigma-Aldrich, St. Louis, USA), and
100 Portuguese individuals without neuropsychiatric disease (self
reported) from blood donor centers throughout Portugal were
included.
CYTOGENETIC ANALYSES, FLUORESCENCE IN SITU HYBRIDIZATION
AND ARRAY-COMPARATIVE GENOMIC HYBRIDIZATION
Cytogenetic analysis and fluorescence in situ hybridiza-
tion (FISH) was performed according to standard pro-
tocols, and array-based comparative genome hybridization
was performed as previously described (Erdogan et al.,
2006).
WHOLE GENOME AMPLIFICATION
When necessary, genomic DNA was uniformly amplified using
GenomiPhi™DNA Amplification Kit (GE Healthcare, Bucking-
hamshire, UK).
MUTATION SCREENING OF KCNQ3
All 15 coding exons and intron-exon boundaries of KCNQ3
(NM_004519.3) were amplified by PCR. Sequencing reactions
were carried out using BigDye® Terminator v 1.1 Cycle Sequenc-
ing Kit (Life Technologies, California, USA) and analyzed by an
ABI 3100 AVANT Genetic Analyzer (Life Technologies, California,
USA). ChromasPro version 1.33 (Technelysium Pty Ltd, Australia)
was used to visualize the data. Nucleotide changes were verified
by a second PCR amplification of non-genome amplified patient
DNA, sequencing and restriction cleavage.
RESTRICTION ENZYME ASSAY FOR DETECTION OF c.1720C> T
(p.P574S) IN KCNQ3
A PCR product of 461 base pairs (bp) encompassing exon 13
of KCNQ3 was amplified using primers KCNQ3_13a: TATTC-
CAAACCCTTATCTCAT and KCNQ3_13b: AAACAGGTGGGG
CTATTA. PCR fragments amplified from the WT allele were
digested into two fragments with lengths 438 and 23 bp by the
restriction enzyme Hpy188III, whereas PCR fragments amplified
from the c.1720C>T allele were digested into three fragments
with lengths 337, 101, and 23 bp.
EXPRESSION PLASMIDS AND CLONING
The plasmids hKV7.2-hKV7.5 in pXOOM or pXOON, hKV7.3-
flag in pNS2z, and hKV7.2-cmyc in pNS2z used in this study
have been described previously (Bentzen et al., 2006; Rasmussen
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FIGURE 6 | KV7.2/KV7.3_P574 complexes still target to the AIS of cultured
hippocampal neurons. Confocal images of cultured rat hippocampal neurons
(10 DIV) expressing KV7.3 WT or KV7.3_P574S (A) and co-transfected with KV7.2
(B). (A) KV7.3 is primarily intracellularly expressed when expressed on its own.
No significant KV7.3 expression is observed at the AIS. (B)When
co-expressing KV7.3 with KV7.2, both channel subunits are observed at the AIS.
KV7.3_P574S displays the same localization characteristics. White arrowhead
points to the location of the AIS. Ankyrin-G: marker of the axon initial
segment, MAP2: marker of the somatodendritic region of neurons. Scale bars
50 and 20µm, respectively.
et al., 2007). KV7.4 cDNA was amplified with PCR and inserted
into pNS2z to generate C-terminally myc-tagged KV7.4. To gen-
erate the extracellularly tagged expression plasmid hKV7.5-3xHA
in pXOOM, 3 HA-tags were inserted into the TM3-TM4 linker of
hKV7.5 by PCR using the primers 5′-CCAGATTACGCGTACCC
TTACGACGTTCCAGATTACGCTGGTAATATTTTTGCCAC-3′
and 5′-GACATCGTAT GGGTAAGCGTAGTCTGGGACGTCG
TATGGGTACTGAGTTTTTGCAGAAAC-3′. Human CD4-WT in
pcDNA3.1 was a kind gift from James Trimmer (University of
California Davis, CA, USA) and has been described earlier (Gu
et al., 2003). The chimera hCD4-hKV7.3CT in pcDNA3.1 was
generated using standard PCR and in-frame insertion of cDNA
Frontiers in Genetics | Behavioral and Psychiatric Genetics April 2013 | Volume 4 | Article 54 | 6
Gilling et al. KV7.3/KV7.5 abnormalities associated with ASDs
FIGURE 7 | CD4-KV7.3Cterm_P574 can target to the AIS. Confocal
images of cultured rat hippocampal neurons (10 DIV) transfected with
CD4 (two upper panels), CD4-KV7.3 C-term (two middle panels) and
CD4-KV7.3_P574S C-term (two lower panels). The panels to the left
illustrate the structure of the chimeric constructs analyzed. CD4-total
reflects total CD4 staining in permeabilized cells. CD4-surface is a
surface staining of the same cells where the CD4 antibody was applied
before permeabilization. The somatodendritic marker MAP2 was
included to indicate the location of the AIS (neurite which is MAP2
negative). As expected, CD4 distributes in a non-polarized manner on
the surface of axon, soma and dendrites. When the C-terminal of KV7.3
is attached to CD4, the reporter redistributes to the axon initial
segment, which illustrates that the KV7.3 C-terminal contains
information for AIS localization. The C-terminus of KV7.3_P574S still has
the ability to direct CD4 to the AIS. White arrowhead points to the
location of the AIS. Scale bars 50 and 20µm, respectively.
corresponding to KV7.3 amino acids 358–873 into Not I and
XhoI sites of the wild-type (WT) construct. The point muta-
tion c.1720C>T leading to the amino acid exchange P574S was
introduced using mutated oligonucleotide extension (PfuTurbo
Polymerase, Stratagene, La Jolla, CA, USA) from the plasmid
template harboring the cDNA of interest, digested withDpnI (Fer-
mentas, St. Leon, Germany) and transformed into E. coli XL1 Blue
cells. All plasmids were verified by complete DNA sequencing of
the cDNA insert (Macrogen Inc., Seoul, Rep. of Korea). The Gene
Bank Accession numbers of the human cDNAs are: NM_004519
(KV7.3), NM_004518 (KV7.3, isoform c), NM_004700 (KV7.4),
and NM_019842 (KV7.5). Protein accession number for KV7.3 is
NP_004510.
HETEROLOGOUS EXPRESSION IN XENOPUS LAEVIS OOCYTES
In vitro transcription
The cRNA were prepared from linearized hKV7.2, hKV7.3 WT
and mutant, KV7.4, and KV7.5 constructs in pXOOM or pXOON
using the Ambion T7 m-Message Machine kit according to the
manufacturer’s instructions (Ambion, Austin, TX, USA). RNA
concentrations were determined by UV spectroscopy, integrity
was confirmed by gel electrophoresis. cRNAs were stored at−80˚C
until injection.
Oocyte isolation and injection
Female Xenopus laevis frogs were anesthetized with Tricain
(2 g/l, Sigma, Brøndby, Denmark) and ovarian lobes were
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FIGURE 8 | No effect of KV7.3_P574S on the localization of KV7.4 and
KV7.5 containing complexes in HEK 293 cells. KV7.4 and KV7.5 were
transiently expressed in HEK 293 cells together with KV7.3 or KV7.3_P574S
and the localization of the expressed subunits analyzed by
immunocytochemistry and confocal microscopy. As illustrated, the
P574S mutation is without effect on the localization pattern of the
complexes that displays a mixed surface and intracellular staining
pattern. Scale bar 20µm.
removed. Oocytes were defolliculated enzymatically in 1% col-
lagenase (Boehringer Mannheim/Roche, Hvidovre, Denmark)
and 0.1% trypsin inhibitor (Sigma) in Kulori’s solution for
1 h followed by wash in Kulori’s solution (in mM: 90 NaCl,
4 KCl, 1 MgCl2, 1 CaCl2, 5 Hepes, pH 7.4) containing 0.1%
BSA (Sigma). Oocytes were injected using a Nanoject microin-
jector (Drummond Scientific, Broomall, PA, USA) with 1 ng
hKV7.2, 7.4, or 7.5 mixed with hKV7.3 WT or hKV7.3_P574S
cRNA (in a 1:1 molar ratio) diluted in 50 nl diethylpyrocar-
bonate treated water. Oocytes were kept in Kulori’s solution
at 19˚C.
Two-electrode voltage-clamp recordings
Currents were recorded at room temperature by two-electrode
voltage-clamp (TEVC) 2 days after injection using a Dagan 2B
amplifier (Clampator 1, Dagan, Chicago, IL, USA). The oocytes
were perfused with Kulori’s solution and pipettes were pulled
from borosilicate glass and had a final tip resistance of 0.5–2.5 MΩ
when filled with 2 M KCl. Data were acquired using Pulse software
(HEKA electronics, Germany) and analyzed with Igor (WaveMet-
rics, Lake Oswego, OR, USA) and GraphPad Prism (GraphPad
Software, San Diego, CA, USA). All experiments were performed
in 3–4 different batches of oocytes.
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FIGURE 9 | Localization and conservation of the SNP c.1720C>T
[p.P574S] in KCNQ3. (A)The KV7 subunits consist of six transmembrane
domains and a long intracellular carboxy-terminal that contains the subunit
interaction domain (sid ) (within the square). The P574 amino acid is located in
the linker region between two coiled-coil regions. Adapted from (Wehling
et al., 2007). (B)The c.1720C nucleotide is conserved between species.
Adapted from the UCSC genome browser hg18. (C) Amino acid alignment of
the si domains from all KV7 channels. The two coiled-coil domains are
depicted as gray boxes and conserved amino acids are marked with an
asterisk. The P574 amino acid is located in the linker region between two
coiled-coil regions and is not conserved between KV7 members. Adapted
from Wehling et al. (2007).
Data analysis
Data are presented as mean± standard error of the mean. For sta-
tistical analyses ANOVA combined with Student-Newman-Keuls
post test was used and p< 0.05 was considered significant (∗).
CELL CULTURES AND TRANSFECTIONS
HEK 293 cells were grown in DMEM (Invitrogen, Glostrup,
Denmark) supplemented with 100 U/ml penicillin, 100 mg/ml
streptomycin and 10% FCS (Sigma-Aldrich, Copenhagen, Den-
mark) at 37˚C in a humidified atmosphere with 5% CO2. Trans-
fections were carried out using the Lipofectamine-Plus Reagent
system (Invitrogen) according to the manufacturer’s instructions.
Hippocampal cultures were prepared as previously described (Ras-
mussen et al., 2007) and transfected at 7–8 days in vitro (DIV)
using the lipofectamine 2000 method (Invitrogen) with a total of
0.9µg of DNA per cover-slip. Transfection was carried out for 1 h
at 37˚C, 5% CO2 after which the neurons were transferred back
to the dishes containing the glial cell layer. Neurons were left for
expression for 48 h.
IMMUNOCYTOCHEMISTRY
HEK 293 cells or primary hippocampal neurons were fixed in 3%
paraformaldehyde in PBS for 15–20 min at room temperature.
Blocking and permeabilization was performed by a 30 min incu-
bation with 0.2% fish skin gelatin in phosphate buffered saline
supplemented with 0.1% Triton X-100 (PBST). The cells were
then incubated for 1 h in primary antibodies diluted in PBST.
Primary antibodies employed were: rabbit anti-c-myc (A-14,
1:50 dilution, Santa Cruz Biotechnology, Heidelberg, Germany),
mouse anti-FLAG (M2, 1:250 dilution, Sigma-Aldrich, Copen-
hagen, Denmark), and rat anti-HA (3F10, 1:50 dilution, Santa
Cruz Biotechnology). For immunofluorescent detection, Alexa
Fluor®–coupled secondary antibodies were diluted in PBST and
applied for 45 min. The cover-slips were mounted in Prolong Gold
(Invitrogen, Glostrup, Denmark).
CONFOCAL MICROSCOPY AND IMAGING
Laser scanning confocal microscopy was performed using the
Leica TCS SP2 system equipped with argon and helium-neon
lasers. Images were acquired using a 63× water immersion objec-
tive, NA 1.2 with a pinhole size of 0.8-1 and a pixel format of
1024× 1024. Line averaging was used to reduce noise. For double-
and triple-labeling experiments sequential scanning was employed
to allow the separation of signals from the individual channels.
Acquired images were treated using Adobe Photoshop CS4 and
Adobe Illustrator CS4.
RESULTS
IDENTIFICATION OF A DE NOVO RECIPROCAL TRANSLOCATION T (3;8)
(Q21;Q24) DISRUPTING KCNQ3
By cytogenetic analysis a de novo t (3;8) (q21;q24) translocation
was identified in Patient A. The breakpoints of this translocation
were mapped using FISH. The breakpoint on chromosome 3
was delineated to a 26 kb region (chr3:131.189.991-131.216.096;
NCBI36/hg18) at 3q21.3 located 10.5 kb downstream of the
thyrotropin-releasing hormone (THR) gene (Figure 1). No anno-
tated human genes or mRNAs are located within this breakpoint
region. On chromosome 8q24.22 the breakpoint was localized
in a 25 kb region (chr8:133.318.034-133.343.450; NCBI36/hg18)
within exon 1 of the KCNQ3 gene (Figure 1). No disease-related
copy number variations were identified by array comparative
genomic hybridization (CGH) in this patient.
IDENTIFICATION OF A RARE VARIANT C.1720C> T IN KCNQ3 IN THREE
UNRELATED ASD PATIENTS
A paternally inherited c.1720C>T missense mutation in exon
13 of KCNQ3 was identified in patient B by direct sequencing
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(Figure 2A). There is no history of psychiatric- or neurological
disorders in this family. The mutation results in an amino acid
change at position 574 replacing proline by serine (p.P574S). By
restriction enzyme assay the c.1720C>T (p.P574S) variant in
KCNQ3 was identified in two additional ASD patients (patient
C and D) (Figure 2B) and was confirmed in patient B. Patient
C inherited the variant from the mother who suffers from major
depression and patient D inherited the variant from the father
who does not suffer from any psychiatric- or neurological disor-
ders (Figure 2B). The c.1720C>T mutation in patients C and D
was confirmed by direct sequencing of a second PCR product from
non-amplified DNA. No c.1720C>T mutations were identified in
96 UK Caucasian and 100 Portuguese controls.
THE P574S SUBSTITUTION IN KV7.3 REDUCES CURRENT THROUGH THE
KV7.3/KV7.5 COMPLEX
To address effects of the mutation P574S on ion channel function,
we heterologously expressed mutant channels in Xenopus laevis
oocytes. Since KV7.3 does not form functional channels on its own
(Schwake et al., 2000), we investigated whether the KV7.3_P574S
mutation could affect the function of other neuronal members
of the KV7 family. KV7.3_P574S or KV7.3 WT was co-expressed
with KV7.2, KV7.4, or KV7.5 inXenopus laevis oocytes and currents
were recorded by TEVC. In agreement with Neubauer et al. (2008),
we found that current levels for KV7.2/KV7.3_P574S were similar
to those of KV7.2/KV7.3 (Figure 3A). Similarly, the function of
KV7.4 channels did not appear to be affected by the mutation, as
oocytes expressing KV7.3_P574S/KV7.4 had similar current lev-
els as KV7.3/KV7.4 (Figure 3B). In a final set of experiments,
we tested the effect of KV7.3_P574S on KV7.5 currents. In line
with previous work by Lerche et al. (2000), co-expression of
KV7.5 with KV7.3 dramatically increased current levels com-
pared to KV7.5 alone (Figure 4). Expression of KV7.3_P574S also
enhanced KV7.5 current levels but to a significantly lesser extent
than WT KV7.3. These results suggest that KV7.3_P574S has not
lost its ability to interact with KV7.5. Since both patients B and
C were heterozygous for the KV7.3_P574S mutation, we mim-
icked the heterozygous state by co-expressing KV7.5 with KV7.3
and KV7.3_P574S in a 2:1:1 ratio. The resulting current levels
were intermediate of that of KV7.3/KV7.5 and KV7.3_P574S/KV7.5,
indicating that (1) KV7.3_P574S is not dominant-negative, and
(2) co-expression of WT does not rescue the KV7.3_P574S phe-
notype. The difference in current levels between the heterozygote
and WT KV7.3/KV7.5 is statistically significant as indicated by
the asterisk in Figure 4B. Meticulous inspection of the curves
in Figure 4B reveals that for KV7.5 expressed alone, there is a
tendency for the current-voltage relationship to flatten out at
higher voltages and this tendency appears to be removed by co-
expression with KV7.3, making the current-voltage curve more
linear.
THE P574S SUBSTITUTION IN KV7.3 DOES NOT AFFECT TRAFFICKING IN
HEK 293 CELLS AND NEURONS
Since the P574S mutation reportedly is without effect upon the
current characteristics of the KV7.2/KV7.3 complex (Miceli et al.,
2009), we decided to investigate whether the P574S mutation could
affect the localization of the heteromeric KV7.2/KV7.3 complex.
We first analyzed the localization of KV7.2 and KV7.3 upon co-
expression in HEK 293 cells. As illustrated in Figure 5, both
channel subunits displayed a primarily intracellular staining pat-
tern. The subunits appeared to co-localize to a large degree in the
intracellular structures and only weak staining could be detected
in association with the cell surface. Importantly, co-expression of
KV7.2 and KV7.3_P574S resulted in a staining pattern that was
indistinguishable from the co-expression of the WT channels.
Thus, KV7.3_P574S does not appear to have an impact on the
localization of the KV7.2/KV7.3 heteromeric complex in HEK 293
cells.
In neurons, the KV7.2/KV7.3 complex is localized to the AIS
(Devaux et al., 2004; Chung et al., 2006; Rasmussen et al., 2007).
We therefore speculated that the specific localization of the com-
plex to the AIS could be disturbed by the P574S mutation. To
address this question, we first examined the localization of KV7.3
and KV7.3_P574S upon exogenous expression in cultured rat hip-
pocampal neurons. As previously reported, singly expressed KV7.3
was primarily observed intracellularly with no significant enrich-
ment in the AIS (Rasmussen et al., 2007). Likewise, KV7.3_P574S
demonstrated a primarily intracellular staining pattern similar to
the WT subunit.
Upon co-expression of KV7.2 and KV7.3, the channel complex
appears in the AIS (Rasmussen et al., 2007). To investigate whether
the KV7.3_P574S mutation perturbed the localization of the com-
plex to the AIS, we transiently expressed KV7.2 with either WT
KV7.3 or KV7.3_P574S in cultured hippocampal neurons. As illus-
trated in Figure 6B, the P574S mutation did not impair the local-
ization of the KV7.2/KV7.3_P574S complex as it localized to the AIS
similar to the WT complex. These results were further emphasized
by experiments using chimeric constructs of the transmembrane
protein CD4 and KV7.3/KV7.3_P574S. We have previously demon-
strated that the ability of KV7.3 to direct the KV7.2/KV7.3 complex
to the AIS critically depends on an ankyrin-G binding sequence in
the C-terminal tail of KV7.3 (Rasmussen et al., 2007). We there-
fore attached the C-terminal tail of KV7.3 to a truncated version
of the CD4 receptor to examine whether this part of KV7.3 would
be sufficient to redirect the otherwise non-polarized protein CD4
to the AIS (Figure 7, left panel). As expected, the truncated ver-
sion of CD4 displayed a non-polarized localization pattern upon
expression in cultured hippocampal neurons (Figure 7, top panel).
Attachment of the KV7.3 C-terminus was sufficient to drive an AIS
localization of the chimera (Figure 7, middle panel). As illustrated,
introduction of the P574S mutation into the chimera was without
effect as the mutated chimera was still able to target efficiently to
the AIS (Figure 7, lower panels).
Since the P574S mutation did not affect the localization of
the classical KV7.2/KV7.3 complex, we investigated the impact of
the mutation on the localization of heteromeric channels includ-
ing the KV7.4 or KV7.5 subunits. We transiently co-expressed WT
KV7.3 or the mutant P574S with either the KV7.4 or the KV7.5 sub-
unit in HEK 293 cells and analyzed the localization of the subunits
by confocal microscopy. As illustrated in Figure 8, KV7.3/KV7.4
and KV7.3/KV7.5 complexes demonstrated a mixed surface and
intracellular staining pattern demonstrating that both KV7.4 and
KV7.5 subunits can pull a fraction of KV7.3 subunits to the cell sur-
face. However, the same localization pattern was observed when
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analyzing the mutant complexes. Thus, the P574S mutation was
without significant effect on the localization of KV7.4 and KV7.5
containing complexes.
DISCUSSION
Mutations in KCNQ3 (and KCNQ2) have been previously
described in patients with rolandic epilepsy and IGE (Neubauer
et al., 2008) including benign neonatal convulsions. A consider-
able proportion of patients with these types of epilepsies also have
ID and/or behavioral problems (ADHD, ASD, anxiety, depression)
(Borgatti et al., 2004; Steinlein et al., 2007; Akanuma et al., 2008;
Tovia et al., 2011) which supports a common genetic etiology
and accordingly suggest KCNQ3 (and KCNQ2) as candidate sus-
ceptibility genes for ID and various psychiatric disorders. This is
substantiated by a KCNQ2 knock-out mouse model that shows
spontaneous seizures and behavioral hyperactivity (Peters et al.,
2005); by finding of two patients with psychomotor retardation
and convulsions with a 8,35 Mb deletion encompassing KCNQ3
(Verheij et al., 2009); and by the association of markers close to
KCNQ3 with bipolar disorder (Avramopoulos et al., 2004; Zandi
et al., 2008; Zhang et al., 2010).
In line with this hypothesis we here demonstrate different
KCNQ3 alterations (truncating mutation, rare SNP with abnor-
mal electrophysiological profile) in four patients with childhood
autism and in one transmitting parent with major depression.
The c.1720C>T [p.P574S] nucleotide change was identified
in three unrelated Portuguese patients with childhood autism. In
two cases (patients B and D) the variant was inherited from an
apparently normal parent and in the third case (patient C) trans-
mitted from a mother with major depression. This nucleotide
change is now annotated as a rare SNP in dbSNP (rs74582884,
Minor Allele Frequency A= 0,012) and was previously reported
in 2 of 62 patients with rolandic epilepsy and in 8 of 455 patients
with IGE but not in 454 healthy controls (Neubauer et al., 2008).
Both patients with rolandic epilepsy inherited the mutation from
a healthy parent. This raises the possibility that the rs74582884
SNP conveys liability for general psychopathology but at the same
time suggests that additional genetic and/or environmental fac-
tors may have an impact on the phenotypical outcome of carriers.
Indeed, the same SNP was reported in a patient with benign famil-
ial neonatal seizures who, in addition, carried a de novo mutation
in KCNQ2 that changed channel gating. Since the SNP in KCNQ3
was inherited from a father and a paternal grandmother without
neurological abnormalities the authors suggested that the SNP
was not responsible for the observed epilepsy (Miceli et al., 2009).
However, our data suggest the c.1720C>T nucleotide change
as a contributing factor. Combining our data with all published
sequencing studies of KCNQ3 shows that rs74582884 is a rare vari-
ant as it is absent in a total of 700 controls (Neubauer et al., 2008;
Miceli et al., 2009).
The proline P574 is located in the linker region between
two subunit interaction domains in the C-terminal region of
KV7.3 (Figure 9A). This part of the protein is involved in sub-
unit assembly, maturation, and transport of channels (Schwake
et al., 2006). The amino acid residue P574 is evolutionally con-
served (Figure 9B), but it is not conserved among the KV7 family
members of voltage-gated potassium channels (Figure 9C). This
indicates that P574 is important for KV7.3 function and this func-
tion is probably not shared by the other KV7 members. Since
KV7.3 is the most promiscuous of the KV7 proteins forming
heterotetrameric channels with KV7.2 (Schroeder et al., 1998),
KV7.4 (Kubisch et al., 1999), and KV7.5 (Schroeder et al., 2000)
we investigated the effect of the P574S change on the localiza-
tion of and current through heteromeric KV7.2/KV7.3_P574S,
KV7.4/KV7.3_P574S, and KV7.5/KV7.3_P574S channels.
There was no significant effect of the P574S amino acid change
on the localization of KV7.3 containing channel complexes neither
in HEK 293 cells (Figures 5 and 8) nor in cultured rat hippocampal
neurons (Figure 6). The data further show that subunit assem-
bly as well as AIS localization were unaffected by the mutation
(Figure 7).
Currents elicited in X. laevis oocytes upon expression of
KV7.2/KV7.3_P574S did not differ from WT currents (Figure 3A)
in agreement with previous reports (Neubauer et al., 2008; Miceli
et al., 2009). Likewise, we did not observe any changes in the
current mediated by KV7.4/KV7.3_P574S complexes (Figure 3B).
However, co-expressing KV7.3_P574S with KV7.5 reduced the
current significantly compared to WT KV7.3 (Figure 4), possibly
due to altered inactivation properties. Mimicking the heterozy-
gous state of the patients showed intermediate current amplitudes
indicating that KV7.3_P574S does not have a dominant-negative
effect; however, the effect of the mutation is not rescued by co-
expression of WT KV7.3. These results show, for the first time,
how the rs74582884 SNP in KCNQ3 identified in patients with
ASD, ID, major depression or various types of epilepsy functionally
impairs the function of a channel complex formed by KV7.3/KV7.5
complexes. Accordingly, KCNQ3 and KCNQ5 (OMIM 607357)
are suggestive susceptibility genes for ASD, ID, major depres-
sion, epilepsy, and due to the considerable overlap in etiologies
also for other psychiatric disorders like ADHD, bipolar disorder,
and anxiety disorder. To our knowledge, this is the first report
associating KV7.5 with a disease.
The physiological relevance of this finding lies in the major
impact these channel complexes underlying the M-current have
for controlling neuronal excitability (Wang et al., 1998; Schroeder
et al., 2000; Cooper and Jan, 2003) and generation of theta oscil-
lations which are involved in memory formation and spatial nav-
igation (Hu et al., 2002; Peters et al., 2005; Wang, 2010). Theta
oscillations are not only observed in the hippocampus but also in
the surrounding limbic structures as well as in the prefrontal cor-
tex (Wang, 2010). These areas of the brain are involved in memory
storage (Morgado-Bernal, 2011), emotional processing (Adolphs,
2010), behavioral monitoring, and valuation of response outcomes
(Wang, 2010) which are all aspects of normal brain functioning
that appear to be affected in individuals with ASD, ID, or psychi-
atric disorders and accordingly might contribute to the observed
phenotypes of the patients presented here. Since several neuro-
transmitters, neuromodulators, and pharmacological drugs can
influence the properties of M-channels (Cooper and Jan, 2003)
it can thus be speculated whether any of these modulators could
improve the quality of life for the patients described here and
potentially other psychiatric patients.
In conclusion, we here present four unrelated ASD patients
with variations in KCNQ3. One patient has a truncating de
www.frontiersin.org April 2013 | Volume 4 | Article 54 | 11
Gilling et al. KV7.3/KV7.5 abnormalities associated with ASDs
novo mutation whereas the other three patients have inher-
ited a c.1720C>T [p.P574S] nucleotide change (rs74582884).
One transmitting parent suffers from major depression whereas
the other two are phenotypically normal. This SNP was pre-
viously reported in patients with rolandic epilepsy, IGE, or
benign neonatal convulsions and accordingly, shows vary-
ing expressivity and reduced penetrance. The p.P574S change
in the KV7.3 channel protein significantly reduces currents
when co-expressed with KV7.5 but not KV7.2 or KV7.4 in
a heterologous expression system. This suggests that spe-
cific dysfunction of the KV7.3/KV7.5 channel may be asso-
ciated with some forms of ASD, ID, major depression,
epilepsy, and possibly other psychiatric disorders and accordingly
KCNQ5 should also be considered a candidate gene for these
disorders.
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